Literature DB >> 22573550

Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens.

Atsushi Suetsugu1, Matthew Katz, Jason Fleming, Mark Truty, Ryan Thomas, Hisataka Moriwaki, Michael Bouvet, Shigetoyo Saji, Robert M Hoffman.   

Abstract

Pancreatic-cancer-patient tumor specimens were initially established subcutaneously in NOD/SCID mice immediately after surgery. The patient tumors were then harvested from NOD/SCID mice and passaged orthotopically in transgenic nude mice ubiquitously expressing red fluorescent protein (RFP). The primary patient tumors acquired RFP-expressing stroma. The RFP-expressing stroma included cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs). Further passage to transgenic nude mice ubiquitously expressing green fluorescent protein (GFP) resulted in tumors that acquired GFP stroma in addition to their RFP stroma, including CAFs and TAMs as well as blood vessels. The RFP stroma persisted in the tumors growing in the GFP mice. Further passage to transgenic nude mice ubiquitously expressing cyan fluorescent protein (CFP) resulted in tumors acquiring CFP stroma in addition to persisting RFP and GFP stroma, including RFP- and GFP-expressing CAFs, TAMs and blood vessels. This model can be used to image progression of patient pancreatic tumors and to visually target stroma as well as cancer cells and to individualize patient therapy.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573550      PMCID: PMC3566777          DOI: 10.1002/jcb.24099

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  33 in total

1.  Heterotransplantation of a human malignant tumour to "Nude" mice.

Authors:  J Rygaard; C O Povlsen
Journal:  Acta Pathol Microbiol Scand       Date:  1969

2.  A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.

Authors:  X Fu; F Guadagni; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens.

Authors:  X Y Fu; J M Besterman; A Monosov; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

4.  Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.

Authors:  H H Fiebig; J R Schmid; W Bieser; H Henss; G W Lohr
Journal:  Eur J Cancer Clin Oncol       Date:  1987-07

5.  Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy.

Authors:  B C Giovanella; J S Stehlin; L J Williams; S S Lee; R C Shepard
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

Review 6.  Considerations in the use of nude mice for cancer research.

Authors:  F E Sharkey; J Fogh
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

7.  Whole-body subcellular multicolor imaging of tumor-host interaction and drug response in real time.

Authors:  Meng Yang; Ping Jiang; Robert M Hoffman
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

8.  Variation in response of xenografts of colo-rectal carcinoma to chemotherapy.

Authors:  K Nowak; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1978-04       Impact factor: 7.640

9.  Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy.

Authors:  P J Selby; V D Courtenay; T J McElwain; M J Peckham; G G Steel
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

10.  Human breast-cancer xenografts in immune-suppressed mice.

Authors:  M J Bailey; J C Gazet; M J Peckham
Journal:  Br J Cancer       Date:  1980-10       Impact factor: 7.640

View more
  22 in total

1.  Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy.

Authors:  David Roife; Ya'an Kang; Li Wang; Bingliang Fang; Stephen G Swisher; Jeffrey E Gershenwald; Shanna Pretzsch; Colin P Dinney; Matthew H G Katz; Jason B Fleming
Journal:  Surgery       Date:  2017-01-09       Impact factor: 3.982

2.  Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.

Authors:  Kei Kawaguchi; Kentaro Miyake; Qinghong Han; Shukuan Li; Yuying Tan; Kentaro Igarashi; Thinzar M Lwin; Takashi Higuchi; Tasuku Kiyuna; Masuyo Miyake; Hiromichi Oshiro; Michael Bouvet; Michiaki Unno; Robert M Hoffman
Journal:  Cell Cycle       Date:  2018-05-21       Impact factor: 4.534

Review 3.  Imaging the Tumor Microenvironment.

Authors:  Valerie S LeBleu
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

4.  Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model.

Authors:  Kei Kawaguchi; Kentaro Igarashi; Takashi Murakami; Tasuku Kiyuna; Scott D Nelson; Sarah M Dry; Yunfeng Li; Tara A Russell; Arun S Singh; Bartosz Chmielowski; Michiaki Unno; Fritz C Eilber; Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-04-20       Impact factor: 4.534

5.  Prolonged exposure to extracellular lumican restrains pancreatic adenocarcinoma growth.

Authors:  X Li; Y Kang; D Roife; Y Lee; M Pratt; M R Perez; B Dai; E J Koay; J B Fleming
Journal:  Oncogene       Date:  2017-05-22       Impact factor: 9.867

6.  The BET bromodomain inhibitor JQ1 suppresses growth of pancreatic ductal adenocarcinoma in patient-derived xenograft models.

Authors:  P L Garcia; A L Miller; K M Kreitzburg; L N Council; T L Gamblin; J D Christein; M J Heslin; J P Arnoletti; J H Richardson; D Chen; C A Hanna; S L Cramer; E S Yang; J Qi; J E Bradner; K J Yoon
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

7.  Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease.

Authors:  Kristina L Go; Daniel Delitto; Sarah M Judge; Michael H Gerber; Thomas J George; Kevin E Behrns; Steven J Hughes; Andrew R Judge; Jose G Trevino
Journal:  Pancreas       Date:  2017-07       Impact factor: 3.327

8.  Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.

Authors:  Yukihiko Hiroshima; Ali Maawy; Cristina A Metildi; Yong Zhang; Fuminari Uehara; Shinji Miwa; Shuya Yano; Sho Sato; Takashi Murakami; Masashi Momiyama; Takashi Chishima; Kuniya Tanaka; Michael Bouvet; Itaru Endo; Robert M Hoffman
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2014-02-04       Impact factor: 1.878

Review 9.  Patient-derived tumor xenografts: transforming clinical samples into mouse models.

Authors:  Despina Siolas; Gregory J Hannon
Journal:  Cancer Res       Date:  2013-06-03       Impact factor: 12.701

Review 10.  Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery.

Authors:  Thinzar M Lwin; Robert M Hoffman; Michael Bouvet
Journal:  J Surg Oncol       Date:  2018-08-06       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.